01 February 2004
Impact of a-tocopherol and vitamin C on endothelial markers in rats with streptozotocin-induced diabetes
Mohamed Haidara, Hemat Khloussy, Hania Ammar, Lobna Abdel Aal KassemMed Sci Monit 2004; 10(2): BR41-46 :: ID: 11582
Abstract
Background:Overloads of reactive oxygen species in diabetes are associated with a number of pathological conditions, such as endothelial damage, which plays an important role in the initial stage of atherosclerosis. Plasma soluble thrombomodulin (sTM) and von Willebrand factor (vWF) have been found to be important markers of endothelial dysfunction.Material/Methods: 33 male Wistar rats were used for this experiment. All rats received standard rat chow and water. 25 rats were made diabetic by intra peritoneal injection of streptozotocin (STZ) (65 mg/kg) and divided into three groups. Group I was allowed free access to food and water, Group II received 30 mg vitamin C daily, and Group III received a-tocopherol in a dose of 600 mg/kg body weight.Results: At the end of the experimental period, there was significant elevation of sTM, vWF, fibrinogen, systolic blood pressure, and mean arterial blood pressure (MAP); however, there was a significant decrease in serum HDL cholesterol in the diabetic group in comparison to controls. Administration of antioxidants (vitamin C and a-tocopherol) caused attenuation of the endothelial damage, as vitamin C administration caused a significant decrease in sTM, vWF, fibrinogen and increased HDL-cholesterol, while a-tocopherol caused a significant decrease in vWF and sTM. Both vitamin C and a-tocopherol caused a significant decrease in systolic blood pressure and mean arterial pressure.Conclusions: Our results suggest that administration of antioxidants may ameliorate the risk of thrombo-embolism in diabetes associated with hypertension.
Keywords: Antioxidants - pharmacology, Arteries - drug effects, Arteries - physiology, Ascorbic Acid - pharmacology, Biological Markers - blood, Blood Pressure - drug effects, Blood Pressure - physiology, Body Weight, Cholesterol, HDL - blood, Diabetes Mellitus, Experimental - blood, Diabetes Mellitus, Experimental - drug therapy, Diabetes Mellitus, Experimental - metabolism, Endothelium, Vascular - drug effects, Endothelium, Vascular - metabolism, Fibrinogen - analysis, Thrombomodulin - blood, alpha-Tocopherol - pharmacology, von Willebrand Factor - analysis, Antioxidants - pharmacology, Arteries - physiology, Ascorbic Acid - pharmacology, Biological Markers - blood, Blood Pressure - physiology, Body Weight, Cholesterol, HDL - blood, Diabetes Mellitus, Experimental - metabolism, Endothelium, Vascular - metabolism, Fibrinogen - analysis, Thrombomodulin - blood, alpha-Tocopherol - pharmacology, von Willebrand Factor - analysis
Editorial
01 February 2025 : Editorial
Editorial: Current Approaches to Screening for Lung Cancer in Smokers and Non-SmokersDOI: 10.12659/MSM.948255
Med Sci Monit 2025; 31:e948255
In Press
Clinical Research
Predicting Cerebral Small Vessel Disease Burden Based on Thromboelastography in Patients with Acute Ischemi...Med Sci Monit In Press; DOI: 10.12659/MSM.946303
Clinical Research
Long-Term Outcomes of Implanon in Managing Adenomyosis: A 3-Year Prospective StudyMed Sci Monit In Press; DOI: 10.12659/MSM.945972
Laboratory Research
Linear Dimensional Accuracy in Maxillomandibular Records: A Comparative Study of Scannable and Transparent ...Med Sci Monit In Press; DOI: 10.12659/MSM.947265
Clinical Research
Efficacy of King's Combined Uterine Suture in Managing Placenta Accreta: A Retrospective AnalysisMed Sci Monit In Press; DOI: 10.12659/MSM.945826
Most Viewed Current Articles
17 Jan 2024 : Review article 6,969,932
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
16 May 2023 : Clinical Research 701,896
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Mar 2024 : Editorial 25,741
Editorial: First Regulatory Approvals for CRISPR-Cas9 Therapeutic Gene Editing for Sickle Cell Disease and ...DOI :10.12659/MSM.944204
Med Sci Monit 2024; 30:e944204
28 Jan 2024 : Review article 20,253
A Review of IgA Vasculitis (Henoch-Schönlein Purpura) Past, Present, and FutureDOI :10.12659/MSM.943912
Med Sci Monit 2024; 30:e943912